Inflammation and vascular remodeling in COVID-19 hearts
Tóm tắt
A wide range of cardiac symptoms have been observed in COVID-19 patients, often significantly influencing the clinical outcome. While the pathophysiology of pulmonary COVID-19 manifestation has been substantially unraveled, the underlying pathomechanisms of cardiac involvement in COVID-19 are largely unknown. In this multicentre study, we performed a comprehensive analysis of heart samples from 24 autopsies with confirmed SARS-CoV-2 infection and compared them to samples of age-matched Influenza H1N1 A (n = 16), lymphocytic non-influenza myocarditis cases (n = 8), and non-inflamed heart tissue (n = 9). We employed conventional histopathology, multiplexed immunohistochemistry (MPX), microvascular corrosion casting, scanning electron microscopy, X-ray phase-contrast tomography using synchrotron radiation, and direct multiplexed measurements of gene expression, to assess morphological and molecular changes holistically. Based on histopathology, none of the COVID-19 samples fulfilled the established diagnostic criteria of viral myocarditis. However, quantification via MPX showed a significant increase in perivascular CD11b/TIE2 + —macrophages in COVID-19 over time, which was not observed in influenza or non-SARS-CoV-2 viral myocarditis patients. Ultrastructurally, a significant increase in intussusceptive angiogenesis as well as multifocal thrombi, inapparent in conventional morphological analysis, could be demonstrated. In line with this, on a molecular level, COVID-19 hearts displayed a distinct expression pattern of genes primarily coding for factors involved in angiogenesis and epithelial-mesenchymal transition (EMT), changes not seen in any of the other patient groups. We conclude that cardiac involvement in COVID-19 is an angiocentric macrophage-driven inflammatory process, distinct from classical anti-viral inflammatory responses, and substantially underappreciated by conventional histopathologic analysis. For the first time, we have observed intussusceptive angiogenesis in cardiac tissue, which we previously identified as the linchpin of vascular remodeling in COVID-19 pneumonia, as a pathognomic sign in affected hearts. Moreover, we identified CD11b + /TIE2 + macrophages as the drivers of intussusceptive angiogenesis and set forward a putative model for the molecular regulation of vascular alterations.
Tài liệu tham khảo
Gupta A, Madhavan MV, Sehgal K et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032. https://doi.org/10.1038/s41591-020-0968-3
Smadja DM, Mentzer SJ, Fontenay M et al (2021) COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Springer, Netherlands
Rovas A, Osiaevi I, Buscher K et al (2021) Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 24:145–157. https://doi.org/10.1007/s10456-020-09753-7
Ackermann M, Verleden SE, Kuehnel M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120–128. https://doi.org/10.1056/NEJMoa2015432
Libby P, Lüscher T (2020) COVID-19 is, in the end, an endothelial disease. Eur Heart J 41:3038–3044. https://doi.org/10.1093/eurheartj/ehaa623
Philippe A, Gendron N, Bory O et al (2021) Von willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis 24:407–411. https://doi.org/10.1007/s10456-021-09789-3
Philippe A, Chocron R, Gendron N et al (2021) Circulating von willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 24:505–517. https://doi.org/10.1007/s10456-020-09762-6
Smadja DM, Guerin CL, Chocron R et al (2020) Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis 23:611–620. https://doi.org/10.1007/s10456-020-09730-0
Basso C, Leone O, Rizzo S et al (2020) Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J 41:3827–3835. https://doi.org/10.1093/eurheartj/ehaa664
Weckbach LT, Curta A, Bieber S et al (2021) Myocardial inflammation and dysfunction in COVID-19-associated myocardial injury. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.120.011713
Ghidini S, Gasperetti A, Winterton D et al (2021) Echocardiographic assessment of the right ventricle in COVID-19: a systematic review. Int J Cardiovasc Imaging 37:3499–3512. https://doi.org/10.1007/s10554-021-02353-6
Goudot G, Chocron R, Augy JL et al (2020) Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-dimer and correlation with right ventricular afterload. Front Med 7:1–11. https://doi.org/10.3389/fmed.2020.586307
Moody WE, Mahmoud-Elsayed HM, Senior J et al (2021) Impact of right ventricular dysfunction on mortality in patients hospitalized with COVID-19, according to race. CJC Open 3:91–100. https://doi.org/10.1016/j.cjco.2020.09.016
Yu C-M, Wong RS-M, Wu EB et al (2006) Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J 82:140–144. https://doi.org/10.1136/pgmj.2005.037515
Basu-Ray I, Almaddah NK, Adeboye A, Soos MP (2021) Cardiac manifestations of coronavirus (COVID-19). StatPearls, Treasure Island
Edouard AR, Felten ML, Hebert JL et al (2004) Incidence and significance of cardiac troponin I release in severe trauma patients. Anesthesiology 101:1262–1268. https://doi.org/10.1097/00000542-200412000-00004
Halushka MK, Vander Heide RS (2021) Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. https://doi.org/10.1016/j.carpath.2020.107300
Tavazzi G, Pellegrini C, Maurelli M et al (2020) Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 22:911–915. https://doi.org/10.1002/ejhf.1828
Albert CL, Carmona-Rubio AE, Weiss AJ et al (2020) The enemy within: sudden-onset reversible cardiogenic shock with biopsy-proven cardiac myocyte infection by severe acute respiratory syndrome coronavirus 2. Circulation 142:1865–1870. https://doi.org/10.1161/CIRCULATIONAHA.120.050097
Zeng JH, Liu YX, Yuan J et al (2020) First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 48:773–777. https://doi.org/10.1007/s15010-020-01424-5
Thomas Aretz H (1987) Myocarditis: the dallas criteria. Hum Pathol 18:619–624. https://doi.org/10.1016/S0046-8177(87)80363-5
Halushka MK, Vander RS (2020) Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. https://doi.org/10.1016/j.carpath.2020.107300
Walsh C, Tafforeau P, Wagner W et al (2021) Hierarchical phase-contrast tomography bridges the gap between intact human organ and cellular scale imaging. bioRxiv. https://doi.org/10.1101/2022.07.02.498430
Liu F, Han K, Blair R et al (2021) SARS-CoV-2 infects endothelial cells In vivo and in vitro. Front Cell Infect Microbiol 11:1–13. https://doi.org/10.3389/fcimb.2021.701278
Chen P, Simons M (2016) When endothelial cells go rogue. EMBO Mol Med 8:1–2. https://doi.org/10.15252/emmm.201505943
Potenta S, Zeisberg E, Kalluri R (2008) The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99:1375–1379. https://doi.org/10.1038/sj.bjc.6604662
Yakupova EI, Maleev GV, Krivtsov AV, Plotnikov EY (2022) Macrophage polarization in hypoxia and ischemia/reperfusion: insights into the role of energetic metabolism. Exp Biol Med. https://doi.org/10.1177/15353702221080130
Shahid F, Lip GYH, Shantsila E (2018) Role of monocytes in heart failure and atrial fibrillation. J Am Heart Assoc 7:1–17. https://doi.org/10.1161/JAHA.117.007849
Fraccarollo D, Neuser J, Möller J et al (2021) Expansion of cd10neg neutrophils and cd14+ hla-drneg/low monocytes driving proinflammatory responses in patients with acute myocardial infarction. Elife 10:e66808
Kawaguchi M, Takahashi M, Hata T et al (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123:594–604. https://doi.org/10.1161/CIRCULATIONAHA.110.982777
Bröcker V, Länger F, Fellous TG et al (2006) Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med 173:1276–1282. https://doi.org/10.1164/rccm.200509-1381OC
Shantsila E, Watson T, Lip GYH (2007) Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49:741–752. https://doi.org/10.1016/j.jacc.2006.09.050
Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20:355–362. https://doi.org/10.1038/s41577-020-0331-4
Ackermann M, Stark H, Neubert L et al (2020) Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. Eur Respir J. https://doi.org/10.1183/13993003.00933-2019
Mentzer SJ, Konerding MA (2014) Intussusceptive angiogenesis: expansion and remodeling of microvascular networks. Angiogenesis 17:499–509. https://doi.org/10.1007/s10456-014-9428-3
Napoli C, Ignarro LJ (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32:1103–1108. https://doi.org/10.1007/s12272-009-1801-1
Ackermann M, Tsuda A, Secomb TW et al (2013) Intussusceptive remodeling of vascular branch angles in chemically-induced murine colitis. Microvasc Res 87:75–82. https://doi.org/10.1016/j.mvr.2013.02.002
Pandita A, Ekstrand M, Bjursten S et al (2021) Intussusceptive angiogenesis in human metastatic malignant melanoma. Am J Pathol 191:2023–2038. https://doi.org/10.1016/j.ajpath.2021.07.009
Ackermann M, Wagner WL, Rellecke P et al (2020) Parvovirus B19-induced angiogenesis in fulminant myocarditis. Eur Heart J 41:1309. https://doi.org/10.1093/eurheartj/ehaa092
Schmaier AA, Pajares Hurtado GM, Manickas-Hill ZJ et al (2021) Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. JCI Insight. https://doi.org/10.1172/jci.insight.151527
Dimova I, Karthik S, Makanya A et al (2019) SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception. J Cell Mol Med 23:3916–3926. https://doi.org/10.1111/jcmm.14269
Chamoto K, Gibney BC, Lee GS et al (2013) Migration of CD11b+ accessory cells during murine lung regeneration. Stem Cell Res 10:267–277. https://doi.org/10.1016/j.scr.2012.12.006
Peled A, Grabovsky V, Habler L et al (1999) The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J Clin Invest 104:1199–1211. https://doi.org/10.1172/JCI7615
Thomas M, Augustin HG (2009) The role of the angiopoietins in vascular morphogenesis. Angiogenesis 12:125–137. https://doi.org/10.1007/s10456-009-9147-3
Penn MS (2009) Editorial: Importance of the SDF-1: CXCR4 axis in myocardial repair. Circ Res 104:1133–1135. https://doi.org/10.1161/CIRCRESAHA.109.198929
Zisa D, Shabbir A, Mastri M et al (2011) Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol - Hear Circ Physiol 301:2422–2432. https://doi.org/10.1152/ajpheart.00343.2011
Zuern CS, Walker B, Sauter M et al (2015) Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis. Clin Res Cardiol 104:1033–1043. https://doi.org/10.1007/s00392-015-0871-y